88 results
Page 4 of 5
8-K
EX-99.1
y560 2zkirxlm
26 Mar 20
Equillium Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Business Update
4:10pm
8-K
EX-99.1
klepd8p017w ro8xc
12 Dec 19
Equillium & Biocon Expand Exclusive Licensing Agreement for Itolizumab to
7:05am
S-3
gj31rurs21l6ermmu1x
13 Nov 19
Shelf registration
5:20pm
8-K
EX-99.2
yy3hyhbm63f55 adk
12 Nov 19
Equillium Reports Third Quarter 2019 Financial Results and Recent Highlights
4:10pm
8-K
EX-99.1
9w6haa5okhhyd rk
12 Nov 19
Equillium Reports Third Quarter 2019 Financial Results and Recent Highlights
4:10pm
8-K
EX-99.2
w4ha3uc7fxjes
1 Oct 19
Entry into a Material Definitive Agreement
4:10pm
8-K
EX-99.1
jhyvqckk64
1 Oct 19
Entry into a Material Definitive Agreement
4:10pm
8-K
EX-99.1
qc28rlfn
12 Aug 19
Equillium Reports Second Quarter 2019 Financial Results and Recent Highlights
4:10pm
8-K
EX-99.1
83rkgu43fkkl273
13 May 19
Equillium Reports First Quarter 2019 Financial Results and Recent Highlights
4:15pm
8-K
EX-99.1
akpvvffqjsmnh3b
1 May 19
Regulation FD Disclosure
12:00am
DEF 14A
mgqwsf1
25 Apr 19
Definitive proxy
4:15pm
10-K
4sjwpbbhjrl1h
27 Mar 19
Annual report
4:11pm
8-K
EX-99.1
9frt71v
27 Mar 19
Equillium Reports Fourth Quarter and Full-Year 2018 Financial Results and Recent Highlights
4:08pm
8-K
EX-99.2
a48da3n2
26 Feb 19
Results of Operations and Financial Condition
4:05pm
8-K
EX-99.1
iesqqo
26 Feb 19
Results of Operations and Financial Condition
4:05pm
10-Q
98jaen5egw5v1y5
15 Nov 18
Quarterly report
4:43pm